AMCP CHEST 25

AMCP CHEST 2025

CHEST 2025, celebrating the 90th anniversary of the American College of Chest Physicians, will take place in Chicago from Oct. 19-22. The annual conference will present recent research in pulmonary, critical care, and sleep medicine, aiming to improve patient outcomes through the prevention, diagnosis, and treatment of chest diseases. Session types will include oral and poster study presentations, case reports, symposia, panel discussions, pro-con debates, and opportunities to do yoga and volunteer.

AMCP CHEST 2025

Day 1

Esmolol Shows Promise in Reducing Mortality in Septic Shock Patients

SGLT2 Inhibitors May Slow the Growth of Early-Stage Lung Cancers

Ensifentrine Improves the Lives of COPD Patients Without Exacerbations

Nerandomilast Slows Idiopathic Pulmonary Fibrosis Progression in US Patients

Day 2

Brensocatib Improves Outcomes in Asian Patients With Bronchiectasis

Dupilumab Appears to Provide Quick Relief in COPD and Type 2...

Dupilumab Improves Patient-Reported COPD Outcomes

In COPD, Mepolizumab Appears to Reduce the Need for Systemic Corticosteroids

Day 3

SGLT2 Inhibitors May Slow the Growth of Early Lung Cancer

Gender Disparities in Farmer’s Lung Disease Treatment

Steroid-Sparing Agents Show Promise in Stabilizing Lung Function in Hypersensitivity Pneumonitis

Private Equity Hospital Acquisitions Linked to Worse Outcomes for Pulmonary Patients

Day 4

COPD Mortality Risk: Demographic Disparities in Hospitalized Patients

Inhaled Dry Powder Treprostinil Shows Safety and Efficacy in PH-ILD

GLP-1 Receptor Agonists May Increase Survival in Patients With T2DM and...

GLP-1 Receptor Agonists Show Promise for Right Heart Failure in PAH

Quick Links